Scilex Holding (SCLX) Net Cash Flow (QoQ) (2020 - 2026)

Scilex Holding (SCLX) Net Cash Flow (QoQ) (2020 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,026,132.38 Bn 93,026,127.42 Bn 7.76 Bn
2 Eli Lilly 1,022.62 Bn 1,017.34 Bn 16.22 Bn
3 Johnson & Johnson 570.65 Bn 548.59 Bn 15.96 Bn
4 AbbVie 398.73 Bn 389.38 Bn 10.78 Bn
5 Merck 295.53 Bn 289.88 Bn 12.09 Bn
6 Amgen 186.30 Bn 174.26 Bn 5.87 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn
8 Pfizer 146.09 Bn 133.32 Bn -1.21 Bn
9 Bristol Myers Squibb 114.98 Bn 104.53 Bn 8.07 Bn
10 Scilex Holding 48.31 Mn -101.62 Mn 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -77.57%
Dec 31, 2025 248.07%
Sep 30, 2025 -96.86%
Jun 30, 2025 -165.59%
Mar 31, 2025 152.19%
Dec 31, 2024 -212.52%
Sep 30, 2024 -122.49%
Jun 30, 2024 452.53%
Mar 31, 2024 -171.12%
Dec 31, 2023 108.29%
Sep 30, 2023 -210.28%
Jun 30, 2023 941.84%
Mar 31, 2023 1,064.88%
Dec 31, 2022 93.11%
Sep 30, 2022 83.11%
Jun 30, 2022 -191.18%
Mar 31, 2022 4,910.19%
Dec 31, 2021 99.58%
Sep 30, 2021 -61,876.55%
Jun 30, 2021 -20.15%